 | • レポートコード：MRC-IM30492 • 出版社/出版日：IMARC / 2023年2月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の本調査レポートによると、2022年に4.5億ドルであった世界のドライアイ症候群市場規模が、2028年までに6.3億ドルに拡大し、予測期間中にCAGR5.67%で成長する見込みです。本書では、ドライアイ症候群の世界市場を調査・分析し、市場の実態を明らかにしており、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、疾患別（蒸発性ドライアイ症候群 、涙液減少型ドライアイ症候群）分析、治療薬別（抗炎症剤、潤滑性点眼剤、自己血清点眼薬）分析、製品別（液体点眼剤、ジェル、リキッドワイプ 、眼軟膏 、その他）分析、流通チャネル別（病院内薬局、小売薬局、オンライン薬局）分析、地域別（北米、欧州、アジア、中東・アフリカ、中南米）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、製造工程、競争状況などの項目が掲載されています。また、本書には、Akorn Operating Company LLC、Alimera Science、Allergan plc.、Auven Therapeutics、Bausch + Lomb Incorporated、GlaxoSmithKline plc、Nicox S.A.、Novartis AGなどの企業情報が含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のドライアイ症候群市場規模：疾患別 - 蒸発性ドライアイ症候群の市場規模 - 涙液減少型ドライアイ症候群の市場規模 ・世界のドライアイ症候群市場規模：治療薬別 - 抗炎症剤の市場規模 - 潤滑性点眼剤の市場規模 - 自己血清点眼薬の市場規模 ・世界のドライアイ症候群市場規模：製品別 - 液体点眼剤における市場規模 - ジェルにおける市場規模 - リキッドワイプにおける市場規模 - 眼軟膏における市場規模 - その他における市場規模 ・世界のドライアイ症候群市場規模：流通チャネル別 - 病院内薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 - オンライン薬局チャネルの市場規模 ・世界のドライアイ症候群市場規模：地域別 - アジアのドライアイ症候群市場規模 - 欧州のドライアイ症候群市場規模 - 北米のドライアイ症候群市場規模 - 中東・アフリカのドライアイ症候群市場規模 - 中南米のドライアイ症候群市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ポーターズファイブフォース分析 ・価格分析 ・製造工程 ・競争状況 |
The global dry eye syndrome market size reached US$ 4.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.67% during 2023-2028.
Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person’s eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global dry eye syndrome market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
Evaporative
Aqueous
Based on the disease type, evaporative dry eye syndrome currently accounts for the highest market share.
Breakup by Drug Type:
Anti-inflammatory Drugs
Lubricant Eye Drops
Autologous Serum Eye Drops
Based on the drug type, anti-inflammatory drugs currently account for the highest market share.
Breakup by Product:
Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Others
Based on the product type, liquid eye drops currently account for the highest market share.
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on the distribution channel, hospital pharmacies currently account for the highest market share.
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
On the geographical front, North America currently represents the biggest market for dry eye syndrome.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being, Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.
Key Questions Answered in This Report
1. What was the size of the global dry eye syndrome market in 2022?
2. What is the expected growth rate of the global dry eye syndrome market during 2023-2028?
3. What are the key factors driving the global dry eye syndrome market?
4. What has been the impact of COVID-19 on the global dry eye syndrome market?
5. What is the breakup of the global dry eye syndrome market based on the disease type?
6. What is the breakup of the global dry eye syndrome market based on the drug type?
7. What is the breakup of the global dry eye syndrome market based on the product?
8. What is the breakup of the global dry eye syndrome market based on the distribution channel?
9. What are the key regions in the global dry eye syndrome market?
10. Who are the key companies/players in the global dry eye syndrome market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Disease Type
5.5 Market Breakup by Drug Type
5.6 Market Breakup by Product
5.7 Market Breakup by Distribution Channels
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Anti-inflammatory Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Lubricant Eye Drops
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Product
8.1 Liquid Drops
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gel
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liquid Wipes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Ointment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 Global Dry Eye Syndrome Industry: SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Global Dry Eye Syndrome Industry: Value Chain Analysis
13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Global Dry Eye Syndrome Industry: Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis
15 Manufacturing Process
15.1 Product Overview
15.2 Raw Material Requirements
15.3 Manufacturing Process
15.4 Key Success and Risk Factors
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Akorn Operating Company LLC
16.3.2 Alimera Science
16.3.3 Allergan plc.
16.3.4 Auven Therapeutics
16.3.5 Bausch + Lomb Incorporated
16.3.6 GlaxoSmithKline plc
16.3.7 Nicox S.A.
16.3.8 Novartis AG
16.3.9 Otsuka Holdings Co., Ltd.
16.3.10 Santen Pharmaceutical Co., Ltd.
Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2022
Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2022
Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2022
Figure 6: Global: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2022
Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Dry Eye Syndrome (Gel) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Dry Eye Syndrome (Retail) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Dry Eye Syndrome (Retail) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Europe: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Europe: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Middle East and Africa: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Middle East and Africa: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Latin America: Dry Eye Syndrome Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Latin America: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Dry Eye Syndrome Industry: SWOT Analysis
Figure 46: Global: Dry Eye Syndrome Industry: Value Chain Analysis
Figure 47: Global: Dry Eye Syndrome Industry: Porter’s Five Forces Analysis
Figure 48: Dry Eye Syndrome Manufacturing: Process Flow